Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Sana Biotechnology Q2 EPS $(0.39) Down From $(0.32) YoY

Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.39) per share. This is a 21.88 percent decrease over losses of $(0.32) per share from the same period last year.
byBill Haddad
August 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.39) per share. This is a 21.88 percent decrease over losses of $(0.32) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For United Therapeutics

By Benzinga Insights
August 2, 10:20 AM
United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $4.12.

UTHR